All In Biotech

Drug Trial Radar · NCT04895696

A Study Evaluating the Efficacy and Safety of Afimetoran Compared With Placebo in Participants With Active Systemic Lupus Erythematosus (SLE)

A Phase 2, Multicenter, Randomized, Double-blind, Placebo-Controlled, Study to Evaluate the Efficacy and Safety of Afimetoran in Participants With Active Systemic Lupus Erythematosus

Last checked: Nov 19, 2026Latest source record: Aug 17, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruitingPivotal-lookingRandomized with 248 participants. This is a heuristic, not a regulatory label.

Status

Active, not recruiting

Enrollment

248

Actual

Start

Oct 11, 2021

Primary completion

Jun 12, 2026

Study completion Apr 22, 2029

Sponsor

Lead sponsor
Beeline Medicines CorporationIndustry
Sponsor type
Industry
First posted
May 20, 2021

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 70 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to evaluate the effectiveness, safety and tolerability of Afimetoran in participants with active Systemic Lupus Erythematosus (SLE). The extension period will provide additional long-term safety and efficacy data and enable those participants initially randomized to placebo to receive treatment with Afimetoran.

Conditions

  • Systemic Lupus Erythematosus

Interventions

  • AfimetoranDrug

    Specified dose on specified days

  • PlaceboOther

    Specified dose on specified days

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Proportion of participants that achieve an SLE (Systemic Lupus Erythematosus) Responder Index (4) (SRI(4)) response at Week 48Time frame: Up to 48 Weeks

Locations

147 sites in 19 countries. Site status is shown where the registry gives one.

  • Local Institution - 0100

    Birmingham, Alabama

  • Local Institution - 0123

    Huntington Beach, California

  • Local Institution - 0170

    La Jolla, California

  • Local Institution - 0159

    La Palma, California

  • Local Institution - 0172

    San Diego, California

  • Local Institution - 0164

    Woodland Hills, California

  • Local Institution - 0121

    Clearwater, Florida

  • Local Institution - 0167

    Kissimmee, Florida

  • Local Institution - 0122

    Orlando, Florida

  • Local Institution - 0173

    Ormond Beach, Florida

  • Local Institution - 0154

    Plantation, Florida

  • Local Institution - 0137

    South Miami, Florida

  • Local Institution - 0155

    Tamarac, Florida

  • Local Institution - 0160

    Atlanta, Georgia

  • Local Institution - 0205

    Suwanee, Georgia

  • Local Institution - 0146

    Orland Park, Illinois

  • Local Institution - 0187

    Hopkinsville, Kentucky

  • Local Institution - 0171

    Baton Rouge, Louisiana

  • Local Institution - 0134

    Wheaton, Maryland

  • Local Institution - 0070

    Eagan, Minnesota

  • Local Institution - 0124

    St Louis, Missouri

  • Local Institution - 0165

    St Louis, Missouri

  • Local Institution - 0091

    Las Vegas, Nevada

  • Local Institution - 0219

    West Long Branch, New Jersey

  • Local Institution - 0140

    Manhasset, New York

  • Local Institution - 0132

    The Bronx, New York

  • Local Institution - 0203

    Charlotte, North Carolina

  • Local Institution - 0103

    Charlotte, North Carolina

  • Local Institution - 0151

    Columbus, Ohio

  • Local Institution - 0042

    Middleburg Heights, Ohio

  • Local Institution - 0152

    Allen, Texas

  • Local Institution - 0197

    Allen, Texas

  • Local Institution - 0136

    Amarillo, Texas

  • Local Institution - 0029

    Mesquite, Texas

  • Local Institution - 0163

    San Antonio, Texas

  • Local Institution - 0223

    Bellevue, Washington

  • Local Institution - 0207

    Buenos Aires, Buenos Aires, Argentina

  • Local Institution - 0128

    Buenos Aires, Buenos Aires, Argentina

  • Local Institution - 0130

    Quilmes, Buenos Aires, Argentina

  • Local Institution - 0195

    San Fernando, Buenos Aires, Argentina

Showing 40 of 147 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.